Alterations in Retrotransposition, Synaptic Connectivity, and Myelination Implicated by Transcriptomic Changes Following Maternal Immune Activation in Nonhuman Primates
Overview
Authors
Affiliations
Background: Maternal immune activation (MIA) is a proposed risk factor for multiple neuropsychiatric disorders, including schizophrenia. However, the molecular mechanisms through which MIA imparts risk remain poorly understood. A recently developed nonhuman primate model of exposure to the viral mimic poly:ICLC during pregnancy shows abnormal social and repetitive behaviors and elevated striatal dopamine, a molecular hallmark of human psychosis, providing an unprecedented opportunity for studying underlying molecular correlates.
Methods: We performed RNA sequencing across psychiatrically relevant brain regions (prefrontal cortex, anterior cingulate, hippocampus) and primary visual cortex for comparison from 3.5- to 4-year-old male MIA-exposed and control offspring-an age comparable to mid adolescence in humans.
Results: We identify 266 unique genes differentially expressed in at least one brain region, with the greatest number observed in hippocampus. Co-expression networks identified region-specific alterations in synaptic signaling and oligodendrocytes. Although we observed temporal and regional differences, transcriptomic changes were shared across first- and second-trimester exposures, including for the top differentially expressed genes-PIWIL2 and MGARP. In addition to PIWIL2, several other regulators of retrotransposition and endogenous transposable elements were dysregulated following MIA, potentially connecting MIA to retrotransposition.
Conclusions: Together, these results begin to elucidate the brain-level molecular processes through which MIA may impart risk for psychiatric disease.
Inhibitory Systems in Brain Evolution: Pathways of Vulnerability in Neurodevelopmental Disorders.
Hanson K, Greiner D, Schumann C, Semendeferi K Brain Behav Evol. 2024; 100(1):29-48.
PMID: 39137740 PMC: 11822052. DOI: 10.1159/000540865.
Dysregulation of myelination-related genes in schizophrenia.
Bergstrom J, Fu M J Neurochem. 2024; 168(9):2227-2242.
PMID: 39086020 PMC: 11449665. DOI: 10.1111/jnc.16152.
Vacharasin J, Ward J, McCord M, Cox K, Imitola J, Lizarraga S Oxf Open Neurosci. 2024; 3:kvae003.
PMID: 38665176 PMC: 11044813. DOI: 10.1093/oons/kvae003.
Alsegehy S, Southey B, Rund L, Johnson R, Rodriguez-Zas S Genes (Basel). 2023; 14(5).
PMID: 37239367 PMC: 10218591. DOI: 10.3390/genes14051007.
Perez-Palomar B, Erdozain A, Erkizia-Santamaria I, Ortega J, Meana J J Neuroimmune Pharmacol. 2023; 18(3):348-365.
PMID: 37208550 PMC: 10577104. DOI: 10.1007/s11481-023-10070-1.